These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11005209)

  • 1. Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma.
    Basolo F; Fiore L; Baldanzi A; Giannini R; Dell'Omodarme M; Fontanini G; Pacini F; Danesi R; Miccoli P; Toniolo A
    Lab Invest; 2000 Sep; 80(9):1413-9. PubMed ID: 11005209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
    Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
    Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease.
    Salmaso C; Bagnasco M; Pesce G; Montagna P; Brizzolara R; Altrinetti V; Richiusa P; Galluzzo A; Giordano C
    Ann N Y Acad Sci; 2002 Jun; 966():496-501. PubMed ID: 12114310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Fas ligand expression in thyrocytes from patients with Graves' disease.
    Hiromatsu Y; Hoshino T; Yagita H; Koga M; Sakisaka S; Honda J; Yang D; Kayagaki N; Okumura K; Nonaka K
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2896-902. PubMed ID: 10443697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases.
    Xu WC; Chen SR; Huang JX; Zheng ZC; Chen LX; Lin JJ; Li YG
    Eur J Histochem; 2007; 51(4):291-300. PubMed ID: 18162459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Chrousos GP; Koutras DA
    Thyroid; 2000 Jul; 10(7):527-32. PubMed ID: 10958304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.
    Mitsiades N; Poulaki V; Mastorakos G; Tseleni-Balafouta ST; Kotoula V; Koutras DA; Tsokos M
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2924-32. PubMed ID: 10443700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.
    Mitsiades N; Poulaki V; Kotoula V; Mastorakos G; Tseleni-Balafouta S; Koutras DA; Tsokos M
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2199-203. PubMed ID: 9626160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.
    Sera N; Kawakami A; Nakashima T; Nakamura H; Imaizumi M; Koji T; Abe Y; Usa T; Tominaga T; Ejima E; Ashizawa K; Yokoyama N; Ishikawa N; Ito K; Eguchi K
    Clin Exp Immunol; 2001 May; 124(2):197-207. PubMed ID: 11422195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis.
    Stassi G; Todaro M; Bucchieri F; Stoppacciaro A; Farina F; Zummo G; Testi R; De Maria R
    J Immunol; 1999 Jan; 162(1):263-7. PubMed ID: 9886394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of apoptosis-related proteins in Hashimoto's thyroiditis and its pathological significance].
    Zhang Y; Ji Q; Zhang W
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):432-4. PubMed ID: 11798914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases.
    Mitsiades N; Poulaki V; Mitsiades CS; Koutras DA; Chrousos GP
    Trends Endocrinol Metab; 2001 Nov; 12(9):384-90. PubMed ID: 11595539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and distribution of S-100, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in tissues of thyroid carcinoma.
    Xu W; Li X; Chen S; Huang J; Lin S; Lin J; Li Y; Tan X
    Eur J Histochem; 2008; 52(3):153-62. PubMed ID: 18840555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-FasL in Hashimoto's thyroiditis.
    Stassi G; Zeuner A; Di Liberto D; Todaro M; Ricci-Vitiani L; De Maria R
    J Clin Immunol; 2001 Jan; 21(1):19-23. PubMed ID: 11321234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis.
    Giordano C; Stassi G; De Maria R; Todaro M; Richiusa P; Papoff G; Ruberti G; Bagnasco M; Testi R; Galluzzo A
    Science; 1997 Feb; 275(5302):960-3. PubMed ID: 9020075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats.
    Blüher M; Krohn K; Wallaschofski H; Braverman LE; Paschke R
    Eur J Endocrinol; 1999 Nov; 141(5):506-11. PubMed ID: 10576768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
    Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W
    Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.